Toschi N, Lista S, Baldacci F, Cavedo E, Zetterberg H, Blennow K, Kilimann I, Teipel SJ, Melo Dos Santos A, Epelbaum S, Lamari F, Genthon R, Habert MO, Dubois B, Floris R, Garaci F, Vergallo A, Hampel H; INSIGHT-preAD study group; Alzheimer Precision Medicine Initiative (APMI). Biomarker-guided clustering of Alzheimer’s disease clinical syndromes. Neurobiol Aging, 2019, e-pub ahead of print (IF 4,40)

Berron D, Cardenas-Blanco A, Bittner D, Metzger CD, Spottke A, Heneka MT, Fliessbach K, Schneider A, Teipel SJ, Wagner M, Speck O, Jessen F, Düzel E. Higher CSF tau levels are related to hippocampal hyperactivity and object mnemonic discrimination on older adults. J Neurosci, 2019, epub ahead of print (IF 6,07)

Brainbridge WA, Berron D, Schütze H, Cardenas-Blanco A, Metzger C, Dobisch L, Bittner D, Glanz W, Spottke A, Rudolph J, Brosseron F, Buerger K, Janowitz D, Fliessbach K, Heneka M, Laske C, Buch-mann M, Peters O,Diesing D, Li S, Priller J, Spruth EJ, Altenstein S, Schneider A, Kofler B, Teipel SJ, Kilimann I, Wiltfang J, Bartels C, Wolsgruber S, Wagner M, Jessen F, Baker CI, Düzel E. Memorability of photographs in subjective cognitive decline and mild cognitive impairment: Implications for cognitive assessment. Alzheimers Dement (Amst), 2019, 11:610-618 (IF 17,13)

Michalowsky B, Xie F, Eichler T, Hertel J, Kaczynski A, Kilimann I, Teipel SJ, Wucherer D, Zwingmann I, Thyrian JR, Hoffmann W. Cost-effectiveness of a collaborative dementia care management-Results of a cluster-randomized controlled trial. Alzheimers Dement, 2019, e-pub ahead of print (IF 17,13)

Miebach L, Wolfsgruber S, Polcher A, Peters O, Menne F, Luther K, Incesoy E, Priller J, Spruth E, Altenstein S, Buerger K, Catak C, Janowitz D, Perneczky R, Utecht J, Laske C, Buchmann M, Schneider A, Fliessbach K, Kalbhen P, Heneka MT, Brosseron F, Spottke A, Roy N, Teipel SJ, Kilimann I, Wiltfang J, Bartels C, Düzel E, Dobisch L, Metzger C, Meiberth D, Ramirez A, Jessen F, Wagner M. Which features of subjective cognitive decline are related to amyloid pathology? Finings from the DELCODE study. Alzheimers Res Ther., 2019, 11(1):66 (IF 7,07)

Brueggen K, Dyrba M, Cardenas-Blanco A, Schneider A, Fliessbach K, Buerger K, Janowitz D, Peters O, Menne F Priller J, Spruth E, Wiltfang J, Vukovich R, Laske C, Buchmann M, Wagner M, Röske S, Spottke A, Rudolph J, Metzger CD, Kilimann I, Dobisch L, Düzel E, Jessen F, Teipel SJ; DELCODE Study Group. Structural integrity in subjective cognitive decline, mild cognitive impairment and Alzheimer’s disease based on multicenter diffusion tensor imaging. J Neurol, 2019, epub ahead of print (IF 4,20)

Betts MJ, Cardenas-Blanco A, Kanowski M, Spottke A, Teipel SJ, Kilimann I, Jessen F, Düzel E. Locus coeruleus MRI contrast is reduced in Alzheimer’s disease dementia and correlates with CSF Aß levels. Alzheimers Dement, 2019, 11:281-285 (IF 17,13)

Ramirez J, Górriz JM, Teipel S. Editorial: Multimodal and Longitudinal Bioimaging Methods for Characterizing the Progressive Course of Dementia. Front Aging Neurosci, 2019, 11:45 (IF 3,63)

Tang Y, Xing Y, Zhu Z, He Y, Li F, Yang J, Liu Q, Li F, Teipel SJ, Zhao G, Jia J. The effects of 7-week cognitive training in patients with vascular cognitive impairment, no dementia (the Cog-Vaccine study): a randomized controlled trial. Alzheimers Dement, 2019, e-pub ahead of print (IF 17,13)

Kernebeck S, Holle D, Pogscheba P, Jordan F, Mertl F, Huldtgren A, Bader S, Kirste T, Teipel SJ, Holle B, Halek M. A Tablet App- and Seonsor-Based Assistive Technology Intervention for Informal Caregivers to Manage the Challenging Behavior of People with Dementia (the insideDEM Study): Protocol for a Feasibility Study. JMIR Res Protoc, 2019, 8(2):e11630 (IF -)

Diehl-Schmid J, Licata A, Goldhardt O, Förstl H, Yakushew I, Otto M, Anderl-Straub S, Beer A, Ludolph AC, Landwehrmeyer GB, Levin J, Danek A, Fliessbach K, Spottke A, Fassbender K, Lyros E, Prudlo J, Krause BJ, Volk A Edbauer D, Schroeter ML, Drzezga A, Kornhuber J, Lauer M; FTLDc Study Group, Grimmer T. FDG-PET underscores the key role of the thalamus in frontotemporal lobar degeneration caused by C9ORF72 mutations. Transl Psychiatry, 2019, 9(1): 54 (IF 5,47)

Sakr FA, Grothe MJ, Cavedo E, Jelistratova I, Habert MO, Dyrba M, Gonzalez-Escamilla G, Bertin H, Locatelli M, Lehericy S, Teipel SJ, Dubois B, Hampel H; for the INSIGHT-preAD study group; Alzheimer Precision Medicine Initiative (APMI). Applicability o in vivo staging of regional amylid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study. Alzheimers Res Ther, 2019, 11(1): 15 (IF 7,07)

Wolfsgruber S, Molinuevo JL, Wagner M, Teunissen CE, Rami L, Coll-Padros N, Bouwman FH, Slot RER, Wesselmann LMP, Peters O, Luther K, Buerger K, Priller J, Laske C, Teipel SJ, Spottke A, Heneka MT, Düzel E, Drzezga A, Wiltfang J, Sikkes SAM, van der Flier WM, Jessen F; Euro-SCD working group. Prevalence of abnormal Alzheimer’s disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples. Alzheimers Res Ther, 2019, 11(1):8 (F 7,07)

Kilimann I, Braungardt T, Thiel F, Hake K, Haufe C, Schneider W, Teipel SJ. Feasibility and effects of a psychotherapeutic group intervention for caregiving relatives of people with dementia. Z Gerontol Geriatr, 2019, epub ahead of print (IF 1,16)

Zwingmann I, Michalowskiy B, Esser A, Kaczynski A, Monsees J, Keller A, Hertel J, Wucherer D, Thyrian JR, Eichler T, Kilimann I, Teipel S, Dreier Wolfgramm A, Hoffmann W. Identifying Unmet Needs of familiy dementia caregivers: results oft he baseline assessment of a cluster-randomized controlled intervention trial. J Alzheimers Dis, 2019, 67(2):527-539 (IF 3,48)

Chiesa PA, Cavedo E, Grothe MJ, Houot M, Teipel SJ, Potier MC, Habert MO, Lista S, Dubois B, Hampel H; INSIGHT-preAD Study Group and the Alzheimer Precision Medicine Initiative (APMI). Relationship between basal forebrain resting-state functional connectivity and brain Amyloid-ß deposition in cognitively intact older adults with subjective memory complaints. Radiology, 2019, 290(1):167-176 (IF 7,30)

Stenzel J, Rühlmann C, Lindner T, Polei S, Teipel SJ, Kurth J, Rominger A, Krause BJ, Vollmar B, Kuhla A. 18F-florbetaben PET/CT imaging in the Alzheimer’s disease mouse model APPswe/PS1dE9. Curr. Alzheimer Res, 2019, 16(1):49-55 (IF 3,29)

Bischof GN, Ewers M, Franzmeier N, Grothe MJ, Hoenig M, Kocagoncu E, Neutzel J, Rowe JB, Strafella A, Drzezga A, van Eimeren T; MINC faculty. Connectomis and molecular imaging in neurodegeneration. Eur J Nucl Med Mol Imaging, 2019, 46(13):2819-2830 (IF 7,18)

Bartrés-Faz D, González-Escamilla G, Vaqué-Alcázar L, Abellaneda-Pérez K, Valls-Pedret C, Ros E, Grothe MJ. Characterizing the Molecular Architecture of Cortical Regions Associated with High Educational Attainment in Older Individuals. J Neurosci, 2019, 39(23):4566-4575 (IF 6,07)

Scherr M, Utz L, tahmasian M, Pasquini L, Grothe MJ, Rauschecker JP, Grimmer T, Drzezga A, Sorg C, Riedl V. Effective connectivity in the default mode network is distinctively disrupted in Alzheimer’s disease-A simultaneous resting-state FDG-PET/fMRI study. Hum Brain Mapp, 2019, e-pub ahead of print (IF 4,55)

Fritz HJ, Ray N, Dyrba M, Sorg C, Teipel SJ, Grothe MJ. The corticotopic organization of the human basal forebrain as revealed by regionally selective functional connectivity profiles. Hum Brain Mapp, 2019, 40(3): 868-878 (IF 4,55)

Düzel, E, Berron D, Schütze H, Cardenas-Blanco A, Metzger C, Betts M, Ziegler G, Chen Y, Dobisch L, Bittner D, Glanz W, Reuter M, Spottke A, Rudolph J, Brosseron F, Buerger K, Janowitz D, Fliessbach K, Heneka M, Laske C, Buchmann M, Nestor P, Peters O, Diesing D, Li S, Priller J, Spruth EJ, Altenstein S, Ramirez A, Schneider A, Kofler B, Speck O, Teipel S, Kilimann I, Dyrba M, Wiltfang J, Bartels C, Wolfsgruber S, Wagner M, Jessen F. CSF total tau levels are associated with hippocampal novelty irrespective of hippocampal volume. Alzheimers Dement (Amst), 2018, 10:782-790, (IF -)

Scheef L, Grothe MJ, Koppara A, Daamen M, Boecker H, Biersack H, Schild HH, Wagner M, Teipel S, Jessen F. Subregional volume reduction of the cholinergic forebrain in subjective cognitive decline (SCD). Neuroimage Clin, 2019, epub ahead of print (IF 4,81)

Hu X, Teunissen C, Spottke A, Heneka MT, Düzel E, Peters O, Li S, Priller J, Bürger K, Teipel SJ, Laske C, Verfaillie S, Barkhof F, Coll-Padrós N, Rami L, Molinuevo JL, van der Flier W, Jessen F. Smaller medial temporal lobe volumes in individuals with subjective cognitive decline and biomarker evidence of Alzheimer’s disease-Data from three memory clinic studies. Alzheimers Dement, 2019, 15(2): 185-193 (IF 14,42)

Körber A, Spitzer C: Risiken und Nebenwirkungen von Psychotherapie – Einführung und Übersicht. Musiktherapeutische Umschau 2019; 40: 340-351